Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Spurious drugs imported from China raises red flag for pharma regulator.

Date: 12-11-2016
Subject: Spurious drugs imported from China raises red flag for pharma regulator
NEW DELHI: China is on the "radar" of the Indian government after a few instances of import of spurious and sub-standard drugs from the country were reported, said officials of a regulatory body for pharmaceuticals.

"Active pharmaceutical ingredient (API) estimated to be worth Rs 18,000 crore are imported in India annually and China is the main source of importing drugs in bulk. About 60 per cent of the API comes from China, while the rest comes from Italy, Japan, Europe and the USA.

"Also, it has come to notice that most of the cases of sub-standard drugs, drugs with dubious origin or suspected label are coming from China. To check such infiltration, we have put China on the radar," said an official of the Drug Controller General of India (DGCI) on condition of anonymity.

Clandestine operators push spurious pharmaceutical ingredients labelled under the name of authorised importers which compromise patients' safety, the official said, adding that during checks, it is often found that the drugs are not sourced from the Chinese manufacturers, whose names are referred to in the documents.

Notably, India imports medicines like antibiotics, anti-diabetic, anti-hypertensive, anti-cancer and other regular drugs from several countries and to keep a tab on such imports, the government has put in place an electronic platform -- ICEGATE -- to check their quality and authenticity.

Under this programme, the government has framed uniform procedures for sampling and inspection of the drug consignments that come from overseas.

"Through ICEGATE, consignments, bills of entry are electronically placed to the customs which are then scrutinised online by the DGCI port for quality and genuinity. The things which are checked for in imported drugs include documentation, quality, originality of labels etc," said the official.

Drug imports are only allowed from companies whose manufacturing units are registered with the Indian drug regulator.

However, at the domestic front, clandestine operators are much less because regular inspections and sampling of drugs are possible within the country.

DGCI in collaboration with state drug controllers have also launched risk-based inspections all across the country to check the quality of medicine and the manufacturing premises for GMP (Good Manufacturing Practice).

"200 units have been identified on the basis of risks and 105 of them have been inspected. None of them were found to be 100 per cent compliant," the official said.

Source : economictimes.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Exim Help

What is New?

Date: 30-10-2021
Notification No. 78/2021-Customs (N.T.)
Seeks to amend Sea Cargo Manifest and Transhipment Regulations 2018.

Date: 13-10-2021
Notification No. 48/2021-Customs
Seeks to reduce BCD on crude and refined soya, sunflower and palm oils till 31.03.2022

Date: 13-10-2021
Notification No. 49/2021-Customs
Seeks to reduce AIDC on crude soya, sunflower and palm oils till 31.03.2022

Date: 07-10-2021
Notification No.80/2021 - Customs (N.T.)
Exchange rates Notification No.80/2021-Cus (NT) dated 07.10.2021.

Date: 07-10-2021
Notification No. 35/2015-2020
Relaxation in Export Policy of Red Sanders Wood - regarding

Date: 06-10-2021
Public Notice No. 21/2015-20
Implementation of MoU between Government of Republic of India and Government of Republic of Malawi for import of pigeon peas from Malawi - reg.

Date: 05-10-2021
Instruction No. 21/2021-Customs
Submission of Intimation of Arrest Report & Incident Report.

Date: 04-10-2021
Notification No. 34/2015-2020 – DGFT
Amendment in Export Policy of Syringes and incorporation of Policy Condition.

Date: 04-10-2021
Public Notice No. 27/2015-2020-DGFT
Allocation of quantity of 5841 MT (raw/refined) Sugar to EU under TRQ scheme for the year 2021-22

Date: 04-10-2021
Notification No. 59/2021-Customs (ADD)
seeks to extend anti dumping duty on 'ceramic tableware and glassware' originating in or exported from Malaysia, to prevent the circumvention of anti dumping duty levied on subejct goods originating in or exported from China PR vide Notification No. 4/2018-Customs(ADD) dated 21st February, 2018.

Exim Guru Copyright © 1999-2021 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.


C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001